Table 5

Prevalence ratio (PR)* of experiencing differing primary care intervals for symptomatic patients with breast cancer

	Wales	England	Scotland	Northern Ireland	Denmark	Ontario	Norway	Manitoba	Victoria	Sweden†
	(n=97)	(n=167)	(n=160)	(n=172)	(n=141)	(n=70)	(n=99)	(n=109)	(n=142)	(n=0)
Interval ≥5 days
PR (95% CI)	Ref	1.7 (0.7 to 4.2)	2.0 (0.8 to 4.9)	1.3 (0.5 to 3.3)	2.0 (0.8 to 4.8)	12.9 (5.9 to 28.2)	2.2 (0.9 to 5.6)	12.9 (5.9 to 28.1)	11.1 (5.1 to 24.4)	n/a
Interval ≥14 days
PR (95% CI)	Ref	1.6 (0.5 to 4.9)	1.5 (0.5 to 4.7)	1.4 (0.5 to 4.3)	2.1 (0.7 to 6.3)	15.1 (5.7 to 40.1)	2.4 (0.8 to 7.4)	14.3 (5.4 to 37.8)	6.7 (2.5 to 18.1)	n/a

Bold indicates significance level at p≤0.05.
*Adjusted for differences in age and comorbidity among patients, with Wales as reference.
†In Sweden, no information on primary care interval was collected.
n/a, not applicable; ref, reference.